Voskoboynik, O.Y. et al. 2016. Synthesis, anticancer and FGFR1 inhibitory activity of isoindolo[2,1-a][1,2,4]triazino[2,3-c]quinazoline derivatives. Medical and Clinical Chemistry. 1 (Apr. 2016), 5–18. DOI:https://doi.org/10.11603/mcch.2410-681X.2016.v0.i1.6123.